Entry Detail



General Information

Database ID:exR0090219
RNA Name:hsa-miR-625-5p
RNA Type:miRNA
Chromosome:chr14
Starnd:+
Coordinate:
Start Site(bp):65471116End Site(bp):65471136
External Links:hsa-miR-625-5p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
PPP2R1A
chr19
52190048
52229518
+
SF3B3
chr16
70523791
70577670
+
LRFN1
chr19
39306568
39315336
-
SLC6A6
chr3
14402576
14489349
+
VPS37B
chr12
122865330
122896127
-
SMARCC2
chr12
56162359
56189567
-
WIZ
chr19
15419978
15449956
-
SLC7A5
chr16
87830023
87869507
-
MED22
chr9
133338312
133348131
-
PPARD
chr6
35342558
35428191
+
FAM102A
chr9
127940582
127980989
-
ABL2
chr1
179099330
179229684
-
PPP6C
chr9
125146573
125189939
-
ABCF2
chr7
151207837
151227166
-
ABHD14A-ACY1
chr3
51974706
51989183
+
BCL9L
chr11
118893875
118925608
-
JUN
chr1
58780791
58784047
-
NUMB
chr14
73275107
73458617
-
SDF2
chr17
28648346
28662189
-
SREBF2
chr22
41833079
41907307
+
COL6A2
chr21
46098112
46132848
+
ACY1
chr3
51983340
51989197
+
E2F1
chr20
33675477
33686385
-
PRDX2
chr19
12796820
12801800
-
MSI1
chr12
120341330
120369164
-
COPS7B
chr2
231781671
231809254
+
CPSF7
chr11
61402641
61430031
-
SCAMP4
chr19
1905372
1926013
+
ITGA5
chr12
54395261
54419266
-
RNF44
chr5
176526712
176538025
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0001434
chr4
106345352
106377902
-
hsa_circ_0001409
chr4
48835417
48859382
+
hsa_circ_0001358
chr3
169694733
169706147
+
hsa_circ_0001146
chr20
34241449
34246936
-
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC010542.4
chr16
66549280
66551189
+
AC145207.5
chr17
81878425
81881106
-
AC234582.1
chr1
155195004
155205495
+
H19
chr11
1995176
2001470
-
LINC00240
chr6
26956932
27059749
+
MALAT1
chr11
65497688
65506516
+
SNHG7
chr9
136721366
136728184
-
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.